Project Studie PACMEL: Paclitaxel +/- GSK1120212 or pazopanib in Melanoma - EudraCT No. 2011-002545-35

Basic data

Title:
Studie PACMEL: Paclitaxel +/- GSK1120212 or pazopanib in Melanoma - EudraCT No. 2011-002545-35
Duration:
01/12/2014 to 31/05/2017
Abstract / short description:
Randomised phase 2 study of paclitaxel with or without GSK1120212 orpazopanib in advanced wt BRAF melanoma

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Essen, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.